F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Fibrosis

Page 1 of 4 ( 160 items )
<<
1
2
3
4
>>

1	Hepatoprotective effects of silybin in liver fibrosis 11/13/2025 6:51:09 AM \| Browse: 6 \| Download: 38
2	Immunoglobulin G4-related disease in the sigmoid colon in patient with severe colonic fibrosis and obstruction: A case report 10/25/2022 11:36:14 AM \| Browse: 561 \| Download: 1462
3	Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease 8/26/2022 9:51:35 AM \| Browse: 552 \| Download: 1229
4	Use of shear wave elastography for the diagnosis and follow-up of biliary atresia: A meta-analysis 8/26/2022 7:50:06 AM \| Browse: 496 \| Download: 1148
5	Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China 7/18/2022 9:47:46 AM \| Browse: 677 \| Download: 2473
6	Anabolic androgenic steroid-induced liver injury: An update 7/13/2022 7:30:59 AM \| Browse: 673 \| Download: 1323
7	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 585 \| Download: 1758
8	Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis 4/29/2022 11:12:04 AM \| Browse: 642 \| Download: 1207
9	Loss of LAT1 sex-dependently delays recovery after caerulein-induced acute pancreatitis 3/11/2022 9:47:59 AM \| Browse: 641 \| Download: 1542
10	Anti-fibrotic effect of adipose-derived stem cells on fibrotic scars 2/25/2022 12:19:16 PM \| Browse: 661 \| Download: 1509
11	Correlation of hepatitis B surface antigen expression with clinicopathological and biochemical parameters in liver biopsies: A comprehensive study 1/21/2022 8:16:14 AM \| Browse: 617 \| Download: 1619
12	Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter? 12/27/2021 5:24:00 AM \| Browse: 554 \| Download: 1493
13	De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation 12/27/2021 5:24:00 AM \| Browse: 641 \| Download: 1321
14	Multiparameter magnetic resonance imaging of liver fibrosis in a bile duct ligation mouse model 12/17/2021 8:56:01 AM \| Browse: 738 \| Download: 2113
15	Application of adipose-derived stem cells in treating fibrosis 11/25/2021 8:31:20 AM \| Browse: 615 \| Download: 1252
16	Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit? 10/20/2021 7:18:39 AM \| Browse: 607 \| Download: 1069
17	Artificial intelligence for hepatitis evaluation 9/9/2021 6:46:56 AM \| Browse: 791 \| Download: 1467
18	Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist? 9/7/2021 8:15:21 AM \| Browse: 779 \| Download: 1337
19	Clinical perspectives, assessment, and mechanisms of metabolic associated fatty liver disease in patients with COVID-19 9/3/2021 11:45:55 AM \| Browse: 748 \| Download: 1253
20	Impact of donor-specific antibodies on long-term graft survival with pediatric liver transplantation 6/23/2021 1:49:40 AM \| Browse: 878 \| Download: 1635
21	Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand? 3/18/2021 10:54:40 AM \| Browse: 847 \| Download: 1441
22	Histopathological evaluation of long-term tenofovir disoproxil fumarate treatment in patients with hepatitis be antigen-negative chronic hepatitis B 3/18/2021 8:34:30 AM \| Browse: 764 \| Download: 1574
23	Histopathology and predominantly progressive, indeterminate and predominately regressive score in hepatitis C virus patients after direct-acting antivirals therapy 1/29/2021 7:57:41 AM \| Browse: 803 \| Download: 2268
24	Autophagy in liver diseases 1/26/2021 4:22:54 PM \| Browse: 844 \| Download: 1551
25	Obeticholic acid attenuates human immunodeficiency virus/alcohol metabolism-induced pro-fibrotic activation in liver cells 11/24/2020 12:41:21 PM \| Browse: 854 \| Download: 2077
26	Efficacy and safety of anti-hepatic fibrosis drugs 11/6/2020 7:36:12 AM \| Browse: 937 \| Download: 2066
27	Advances in the treatment of nonalcoholic steatohepatitis 10/29/2020 5:34:30 AM \| Browse: 1080 \| Download: 2061
28	Periportal thickening on magnetic resonance imaging for hepatic fibrosis in infantile cholestasis 6/6/2020 2:43:56 PM \| Browse: 1140 \| Download: 2311
29	Macrophages in metabolic associated fatty liver disease 4/28/2020 8:04:30 AM \| Browse: 1018 \| Download: 1653
30	Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma 1/16/2020 7:58:40 AM \| Browse: 1044 \| Download: 1890
31	Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C 1/13/2020 11:27:12 AM \| Browse: 1302 \| Download: 1936
32	Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source 9/7/2019 4:43:36 AM \| Browse: 1174 \| Download: 2613
33	Layered enhancement at magnetic resonance enterography in inflammatory bowel disease: A meta-analysis 8/21/2019 9:19:18 AM \| Browse: 1208 \| Download: 2304
34	Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease 7/28/2019 10:51:57 AM \| Browse: 982 \| Download: 1375
35	Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets 7/6/2019 6:23:58 AM \| Browse: 1401 \| Download: 2486
36	Roles of hepatic stellate cells in acute liver failure: From the perspective of inflammation and fibrosis 5/27/2019 8:24:36 AM \| Browse: 1064 \| Download: 1997
37	Effectiveness of venous thromboembolism prophylaxis in patients with liver disease 4/26/2019 3:40:00 AM \| Browse: 1127 \| Download: 2034
38	Repurposing drugs to target nonalcoholic steatohepatitis 4/18/2019 5:48:09 AM \| Browse: 1211 \| Download: 1963
39	Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication 3/27/2019 10:37:20 AM \| Browse: 1338 \| Download: 2634
40	Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus 3/20/2019 5:32:10 AM \| Browse: 1362 \| Download: 2660
41	Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice 3/20/2019 5:32:10 AM \| Browse: 1336 \| Download: 2101
42	Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects 2/26/2019 11:29:04 AM \| Browse: 1296 \| Download: 1968
43	Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression 1/26/2019 11:40:14 AM \| Browse: 1492 \| Download: 1881
44	Correlation analysis of collagen proportionate area in Budd-Chiari syndrome: A preliminary clinicopathological study 1/26/2019 8:24:19 AM \| Browse: 1121 \| Download: 2102
45	Current status, problems, and perspectives of non-alcoholic fatty liver disease research 1/14/2019 2:54:12 PM \| Browse: 1444 \| Download: 2126
46	Role of cenicriviroc in the management of nonalcoholic fatty liver disease 12/27/2018 8:56:32 AM \| Browse: 1092 \| Download: 1688
47	Management of local recurrence after endoscopic resection of neoplastic colonic polyps 12/21/2018 6:09:14 AM \| Browse: 1201 \| Download: 1886
48	Liver as a target of human immunodeficiency virus infection 11/13/2018 8:04:45 AM \| Browse: 1313 \| Download: 1974
49	Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer 10/18/2018 10:13:24 AM \| Browse: 1211 \| Download: 1864
50	A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease 9/7/2018 9:21:44 AM \| Browse: 1228 \| Download: 2442

Page 1 of 4 ( 160 items )
<<
1
2
3
4
>>

1	Hepatoprotective effects of silybin in liver fibrosis 11/13/2025 6:51:09 AM \| Browse: 6 \| Download: 38
2	Immunoglobulin G4-related disease in the sigmoid colon in patient with severe colonic fibrosis and obstruction: A case report 10/25/2022 11:36:14 AM \| Browse: 561 \| Download: 1462
3	Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease 8/26/2022 9:51:35 AM \| Browse: 552 \| Download: 1229
4	Use of shear wave elastography for the diagnosis and follow-up of biliary atresia: A meta-analysis 8/26/2022 7:50:06 AM \| Browse: 496 \| Download: 1148
5	Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China 7/18/2022 9:47:46 AM \| Browse: 677 \| Download: 2473
6	Anabolic androgenic steroid-induced liver injury: An update 7/13/2022 7:30:59 AM \| Browse: 673 \| Download: 1323
7	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 585 \| Download: 1758
8	Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis 4/29/2022 11:12:04 AM \| Browse: 642 \| Download: 1207
9	Loss of LAT1 sex-dependently delays recovery after caerulein-induced acute pancreatitis 3/11/2022 9:47:59 AM \| Browse: 641 \| Download: 1542
10	Anti-fibrotic effect of adipose-derived stem cells on fibrotic scars 2/25/2022 12:19:16 PM \| Browse: 661 \| Download: 1509
11	Correlation of hepatitis B surface antigen expression with clinicopathological and biochemical parameters in liver biopsies: A comprehensive study 1/21/2022 8:16:14 AM \| Browse: 617 \| Download: 1619
12	Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter? 12/27/2021 5:24:00 AM \| Browse: 554 \| Download: 1493
13	De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation 12/27/2021 5:24:00 AM \| Browse: 641 \| Download: 1321
14	Multiparameter magnetic resonance imaging of liver fibrosis in a bile duct ligation mouse model 12/17/2021 8:56:01 AM \| Browse: 738 \| Download: 2113
15	Application of adipose-derived stem cells in treating fibrosis 11/25/2021 8:31:20 AM \| Browse: 615 \| Download: 1252
16	Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit? 10/20/2021 7:18:39 AM \| Browse: 607 \| Download: 1069
17	Artificial intelligence for hepatitis evaluation 9/9/2021 6:46:56 AM \| Browse: 791 \| Download: 1467
18	Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist? 9/7/2021 8:15:21 AM \| Browse: 779 \| Download: 1337
19	Clinical perspectives, assessment, and mechanisms of metabolic associated fatty liver disease in patients with COVID-19 9/3/2021 11:45:55 AM \| Browse: 748 \| Download: 1253
20	Impact of donor-specific antibodies on long-term graft survival with pediatric liver transplantation 6/23/2021 1:49:40 AM \| Browse: 878 \| Download: 1635
21	Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand? 3/18/2021 10:54:40 AM \| Browse: 847 \| Download: 1441
22	Histopathological evaluation of long-term tenofovir disoproxil fumarate treatment in patients with hepatitis be antigen-negative chronic hepatitis B 3/18/2021 8:34:30 AM \| Browse: 764 \| Download: 1574
23	Histopathology and predominantly progressive, indeterminate and predominately regressive score in hepatitis C virus patients after direct-acting antivirals therapy 1/29/2021 7:57:41 AM \| Browse: 803 \| Download: 2268
24	Autophagy in liver diseases 1/26/2021 4:22:54 PM \| Browse: 844 \| Download: 1551
25	Obeticholic acid attenuates human immunodeficiency virus/alcohol metabolism-induced pro-fibrotic activation in liver cells 11/24/2020 12:41:21 PM \| Browse: 854 \| Download: 2077
26	Efficacy and safety of anti-hepatic fibrosis drugs 11/6/2020 7:36:12 AM \| Browse: 937 \| Download: 2066
27	Advances in the treatment of nonalcoholic steatohepatitis 10/29/2020 5:34:30 AM \| Browse: 1080 \| Download: 2061
28	Periportal thickening on magnetic resonance imaging for hepatic fibrosis in infantile cholestasis 6/6/2020 2:43:56 PM \| Browse: 1140 \| Download: 2311
29	Macrophages in metabolic associated fatty liver disease 4/28/2020 8:04:30 AM \| Browse: 1018 \| Download: 1653
30	Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma 1/16/2020 7:58:40 AM \| Browse: 1044 \| Download: 1890
31	Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C 1/13/2020 11:27:12 AM \| Browse: 1302 \| Download: 1936
32	Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source 9/7/2019 4:43:36 AM \| Browse: 1174 \| Download: 2613
33	Layered enhancement at magnetic resonance enterography in inflammatory bowel disease: A meta-analysis 8/21/2019 9:19:18 AM \| Browse: 1208 \| Download: 2304
34	Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease 7/28/2019 10:51:57 AM \| Browse: 982 \| Download: 1375
35	Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets 7/6/2019 6:23:58 AM \| Browse: 1401 \| Download: 2486
36	Roles of hepatic stellate cells in acute liver failure: From the perspective of inflammation and fibrosis 5/27/2019 8:24:36 AM \| Browse: 1064 \| Download: 1997
37	Effectiveness of venous thromboembolism prophylaxis in patients with liver disease 4/26/2019 3:40:00 AM \| Browse: 1127 \| Download: 2034
38	Repurposing drugs to target nonalcoholic steatohepatitis 4/18/2019 5:48:09 AM \| Browse: 1211 \| Download: 1963
39	Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication 3/27/2019 10:37:20 AM \| Browse: 1338 \| Download: 2634
40	Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus 3/20/2019 5:32:10 AM \| Browse: 1362 \| Download: 2660
41	Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice 3/20/2019 5:32:10 AM \| Browse: 1336 \| Download: 2101
42	Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects 2/26/2019 11:29:04 AM \| Browse: 1296 \| Download: 1968
43	Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression 1/26/2019 11:40:14 AM \| Browse: 1492 \| Download: 1881
44	Correlation analysis of collagen proportionate area in Budd-Chiari syndrome: A preliminary clinicopathological study 1/26/2019 8:24:19 AM \| Browse: 1121 \| Download: 2102
45	Current status, problems, and perspectives of non-alcoholic fatty liver disease research 1/14/2019 2:54:12 PM \| Browse: 1444 \| Download: 2126
46	Role of cenicriviroc in the management of nonalcoholic fatty liver disease 12/27/2018 8:56:32 AM \| Browse: 1092 \| Download: 1688
47	Management of local recurrence after endoscopic resection of neoplastic colonic polyps 12/21/2018 6:09:14 AM \| Browse: 1201 \| Download: 1886
48	Liver as a target of human immunodeficiency virus infection 11/13/2018 8:04:45 AM \| Browse: 1313 \| Download: 1974
49	Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer 10/18/2018 10:13:24 AM \| Browse: 1211 \| Download: 1864
50	A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease 9/7/2018 9:21:44 AM \| Browse: 1228 \| Download: 2442